Effect of Intensive Insulin Therapy and Pentastarch Resuscitation on Acute Kidney Injury in Severe Sepsis

American Journal of Kidney Diseases

Volumn 52, Issue 1, 2008, Pages 13-17

  Thomas, George ^a   Balk, Ethan M ^b   Jaber, Bertrand L ^a  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; DEXTRAN; GELATIN; GLUCOSE; HETASTARCH; INSULIN; RINGER LACTATE SOLUTION;

ACUTE KIDNEY INJURY; ANAPHYLAXIS; BLOOD CLOTTING DISORDER; CAPILLARY PERMEABILITY; CLINICAL TRIAL; COST BENEFIT ANALYSIS; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; CRYSTALLOID; DIALYSIS; DISEASE SEVERITY; EDITORIAL; EUROPE; FLUID RESUSCITATION; GERMANY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE; INTENSIVE CARE UNIT; KIDNEY FAILURE; KIDNEY INJURY; MOLECULAR WEIGHT; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; RANDOMIZATION; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; SCORING SYSTEM; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT; TISSUE PERFUSION;

EID: 45449118287     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.04.008     Document Type: Editorial

References (31)

1. Schrier R.W., and Wang W. Acute renal failure and sepsis. N Engl J Med 351 (2004) 159-169
2. McCowen K.C., Malhotra A., and Bistrian B.R. Stress-induced hyperglycemia. Crit Care Clin 17 (2001) 107-124
3. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (2001) 1359-1367
4. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 354 (2006) 449-461
5. Krinsley J.S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79 (2004) 992-1000
6. Wang L.C., Lei S., Wu Y.C., et al. Intensive insulin therapy in critically ill patients. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 18 (2006) 748-750
7. Bellomo R. Fluid resuscitation: Colloids vs. crystalloids. Blood Purif 20 (2002) 239-242
8. Perel P., and Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 4 (2007) CD000567
9. Treib J., Baron J.F., Grauer M.T., and Strauss R.G. An international view of hydroxyethyl starches. Intensive Care Med 25 (1999) 258-268
10. Dickenmann M., Oettl T., and Mihatsch M.J. Osmotic nephrosis: Acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis 51 (2008) 491-503
11. Langouche L., Vanhorebeek I., Vlasselaers D., et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 115 (2005) 2277-2286
12. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care?. J Clin Invest 114 (2004) 1187-1195
13. Thomas G., Rojas M.C., Epstein S.K., Balk E.M., Liangos O., and Jaber B.L. Insulin therapy and acute kidney injury in critically ill patients: A systematic review. Nephrol Dial Transplant 22 (2007) 2849-2855
14. Van den Berghe G., Wilmer A., Milants I., et al. Intensive insulin therapy in mixed medical/surgical intensive care units: Benefit versus harm. Diabetes 55 (2006) 3151-3159
15. Van den Berghe G. Insulin therapy in the intensive care unit should be targeted to maintain blood glucose between 4.4 mmol/l and 6.1 mmol/l. Diabetologia 51 (2008) 911-915
16. The George Institute. Normoglycemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation (NICE-SUGAR STUDY). http://www.clinicaltrials.gov/ct/show/NCT00220987 Accessed March 10, 2008
17. Bellomo R., and Egi M. Glycemic control in the intensive care unit: Why we should wait for NICE-SUGAR. Mayo Clin Proc 80 (2005) 1546-1548
18. GLUCONTROL Study: Comparing the Effects of Two Glucose Control Regimens by Insulin in Intensive Care Unit Patients. http://www.clinicaltrials.gov/ct/show/NCT00107601 Accessed March 10, 2008
19. Malhotra A. Intensive insulin in intensive care. N Engl J Med 354 (2006) 516-518
20. Van den Berghe G., Wouters P.J., Bouillon R., et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 31 (2003) 359-366
21. Finney S.J., Zekveld C., Elia A., and Evans T.W. Glucose control and mortality in critically ill patients. JAMA 290 (2003) 2041-2047
22. Ellger B., Debaveye Y., Vanhorebeek I., et al. Survival benefits of intensive insulin therapy in critical illness: Impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes 55 (2006) 1096-1105
23. Ragaller M.J., Theilen H., and Koch T. Volume replacement in critically ill patients with acute renal failure. J Am Soc Nephrol 12 suppl 17 (2001) S33-S39
24. Legendre C., Thervet E., Page B., Percheron A., Noel L.H., and Kreis H. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 342 (1993) 248-249
25. Deman A., Peeters P., and Sennesael J. Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: A retrospective, multicentre analysis. Nephrol Dial Transplant 14 (1999) 1517-1520
26. Himpe D., Van Cauwelaert P., Neels H., et al. Priming solutions for cardiopulmonary bypass: Comparison of three colloids. J Cardiothorac Vasc Anesth 5 (1991) 457-466
27. Dehne M.G., Muhling J., Sablotzki A., Papke G., Kuntzsch U., and Hempelmann G. Effect of hydroxyethyl starch solution on kidney function in surgical intensive care patients. Anasthesiol Intensivmed Notfallmed Schmerzther 32 (1997) 348-354
28. Schortgen F., Lacherade J.C., Bruneel F., et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: A multicentre randomised study. Lancet 357 (2001) 911-916
29. Wiedermann C.J. Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis. BMC Emerg Med 8 (2008) 1
30. De Labarthe A., Jacobs F., Blot F., and Glotz D. Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient. Am J Med 111 (2001) 417-418
31. Mehta R.L., Kellum J.A., Shah S.V., et al. Acute Kidney Injury Network (AKIN): Report of an initiative to improve outcomes in acute kidney injury. Crit Care 11 (2007) R31